Michael J. Brown - Feb 2, 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
Stock symbol
MNPR
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 06:34 PM
Previous filing
Feb 14, 2022
Next filing
Feb 24, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +15.1K $0.00 15.1K Feb 2, 2022 Common Stock 15.1K $2.80 Direct F1
transaction MNPR Restricted Stock Units Award $0 +11.4K $0.00 11.4K Feb 2, 2022 Common Stock 11.4K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.
F2 RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.